New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale
January 11, 2021
Illumina Connected Analytics: Connect, see, and read data directly in the cloud SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large [...]
January 11, 2021
SAN DIEGO -- With genetic sequencing at the forefront of precision medicine, Illumina (NASDAQ: ILMN) is pleased to announce a portfolio of new and expanded oncology partnerships that further the company’s commitment to develop standardized, globally distributable tools for precision oncology. Speaking today at the 39th Annual J.P. Morgan Healthcare Conference in San Francisco, California, Illumina [...]
January 11, 2021
Combination of Thermo Fisher’s market leading Orbitrap mass spectrometer portfolio with Seer Proteograph™ Product Suite to expand availability of end-to-end proteomics in new markets REDWOOD CITY, Calif. -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that it has signed a non-exclusive commercial agreement with Thermo Fisher [...]
January 11, 2021
Environmental labs can now use Waters Xevo TQ-XS APGC-MS/MS system for routine, highly sensitive testing with improved robustness NEWS SUMMARY: Under SGS AXYS Method 16130, the Waters™ Xevo™ TQ-XS mass spectrometer is an accepted alternative technology for dioxin analysis based on updated guidelines from the U.S. Environmental Protection Agency Waters collaborated with SGS AXYS Analytical Services Ltd. to validate [...]
Seer and Bruker Sign Commercial Agreement to Expand Market for Unbiased, Deep Proteomics
January 11, 2021
Joint offering of Seer’s Proteograph™ Product Suite with Bruker’s high-performance timsTOF™ Pro mass spectrometer provides a complete proteomics solution to simplify customer adoption REDWOOD CITY, Calif. -- Seer (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, announced today that they have signed a non-exclusive commercial agreement with Bruker Corporation, one [...]
ZEISS is Revolutionizing Customized Automation in Microscopy
January 11, 2021
Targeted Solutions Provide a Rapid ROI for Unique Customer Requirements Jena, Germany | ZEISS Research Microscopy Solutions ZEISS today introduces ZEISS Solutions Lab, an innovative service, that provides its customers with rapid access to new applications for their microscopy systems or correlative microscopy suites. ZEISS Solutions Lab enables customers to select, or to drive demand [...]
January 11, 2021
Multiyear partnership brings together advanced technology, industry expertise and scale to help researchers interpret an unprecedented amount of biomedical data and derive insights to advance the treatment of human diseases CAMBRIDGE, Mass., SOUTH SAN FRANCISCO, Calif., and REDMOND, Wash. — On Monday, Broad Institute of MIT and Harvard, Verily, an Alphabet company, and Microsoft Corp. announced [...]
NuProbe Closes $42M Fundraising
January 11, 2021
HOUSTON and SHANGHAI — NuProbe, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing panels, announces the closing of its oversubscribed $42M fundraising. The lead investors for this financing round are BioTrack Capital and Yonghua Capital. The proceeds will be used to expand the commercial team in both the US and China, develop new NGS products, and file [...]
Unchained Labs sticks it to viruses, launches new mRNA vaccine application on Stunner!
January 11, 2021
Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting researchers the right tool for the job, launched its new mRNA vaccine application on Stunner today. Stunner is the only platform that can simultaneously quantify the total amount of mRNA and measure the size distribution of lipid nanoparticles – two critical qualities of these novel [...]
Tecan invests in Labforward to further drive lab digitalization
January 11, 2021
Tecan participates as lead investor in series B financing round of Labforward, a provider of smart lab software tools for research labs Investment of EUR 4 million builds on ongoing collaboration with Labforward in the area of connectivity tools for Tecan detection devices Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) announced today that [...]

